- Home
- AMPY vs ADCT Comparison
AMPY vs ADCT Comparison
Compare AMPY & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- ADCT
- Stock Information
- Founded
- AMPY 2011
- ADCT 2011
- Country
- AMPY United States
- ADCT Switzerland
- Employees
- AMPY N/A
- ADCT N/A
- Industry
- AMPY Oil & Gas Production
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- ADCT Health Care
- Exchange
- AMPY Nasdaq
- ADCT Nasdaq
- Market Cap
- AMPY 265.7M
- ADCT 224.3M
- IPO Year
- AMPY 2011
- ADCT 2020
- Fundamental
- Price
- AMPY $5.76
- ADCT $1.97
- Analyst Decision
- AMPY Strong Buy
- ADCT Strong Buy
- Analyst Count
- AMPY 3
- ADCT 5
- Target Price
- AMPY $10.00
- ADCT $8.00
- AVG Volume (30 Days)
- AMPY 241.3K
- ADCT 1.7M
- Earning Date
- AMPY 11-06-2024
- ADCT 11-07-2024
- Dividend Yield
- AMPY N/A
- ADCT N/A
- EPS Growth
- AMPY N/A
- ADCT N/A
- EPS
- AMPY 1.55
- ADCT N/A
- Revenue
- AMPY $304,645,000.00
- ADCT $70,717,000.00
- Revenue This Year
- AMPY $8.94
- ADCT $6.58
- Revenue Next Year
- AMPY N/A
- ADCT $11.78
- P/E Ratio
- AMPY $3.69
- ADCT N/A
- Revenue Growth
- AMPY 17.42
- ADCT N/A
- 52 Week Low
- AMPY $3.56
- ADCT $1.28
- 52 Week High
- AMPY $8.15
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- AMPY 30.59
- ADCT 43.59
- Support Level
- AMPY $5.76
- ADCT $1.90
- Resistance Level
- AMPY $6.18
- ADCT $2.21
- Average True Range (ATR)
- AMPY 0.18
- ADCT 0.42
- MACD
- AMPY -0.06
- ADCT -0.03
- Stochastic Oscillator
- AMPY 8.08
- ADCT 9.76
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana, and Eagle Ford.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.